BFC Planning’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BFC Planning's PALI Position: Q4 2024 in Review
BFC Planning sold out of Palisade Bio (PALI) in Q4 2024, closing a stake of 5 shares — an estimated $18 sold.
BFC Planning first reported a position in PALI in Q3 2024 and held it in 1 quarter. The position peaked at $18 in Q3 2024. 10 funds tracked by Wall St. Rank hold PALI as of Q4 2024.
- BFC Planning reported no remaining Palisade Bio position as of Q4 2024 after selling out during the quarter.
- BFC Planning sold 5 Palisade Bio shares in Q4 2024, an estimated $18.
- BFC Planning first reported a position in Palisade Bio in Q3 2024 and held it in 1 quarter.
- BFC Planning's Palisade Bio position peaked at $18 in Q3 2024.
- 10 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2024.
Based on BFC Planning's 13F filing for Q4 2024, filed 29 Oct 2026.